We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In a survey of adults with diabetes, 50% said they ...

Employer healthcare costs are expected to increase by 9% next year, with pricey pharmacy expenses such as GLP-1s being the main driver. Because GLP-1s have demonstrated clinically significant results ...

As GLP-1s have risen in popularity, physicians have been the subject of blame and criticized for being too quick to prescribe these weight loss medications. But according to newly released survey data ...

Despite the chatter around semaglutide, tirzepatide, and similar therapies, GLP-1 anti-obesity medications aren’t as widely used as social media saturation might have you believe — yet. As health care ...

The use of GLP-1 medications like semaglutide for weight loss has increased twofold over the past decade, but declined in use among those with type 2 diabetes, according to a new study, and the ...

If you’ve started or are interested in starting a weight-loss drug like Ozempic, Wegovy, or Zepbound, you are far from alone. Use of glucagon-like peptide-1 receptor agonists, aka GLP-1s, increased 40 ...

The roughly two-year shortage of GLP-1s has officially come to an end. That means, after May 22, compounding pharmacies can no longer produce any copies of the popular diabetes and weight loss drugs, ...

If there are two topics medical marketers can’t get enough of, it’s GLP-1s and the ongoing crackdown on DTC pharma ads. This week’s episode of the MM+M Podcast delves into what happens when patients ...

A series where we find out which products the professionals (who really know what they’re talking about) actually use and really stand behind. Read more here. As Catherine Deneuve once said, “At a ...